Pre-order Enquiry
Request Free Sample
Europe Insulin Like Growth Factor I Market Report 2018
SKU ID : XY-12386386 | Publishing Date : 21-May-2018 | No. of pages : 107
Request Sample
Request Customization
Check DiscountsDetailed TOC of Europe Insulin Like Growth Factor I Market Report 2018
Table of ContentsEurope Insulin Like Growth Factor I Market Report 2012-2023
1 Insulin Like Growth Factor I Overview
1.1 Product Overview and Scope of Insulin Like Growth Factor I
1.2 Classification of Insulin Like Growth Factor I by Product Category
1.2.1 Europe Insulin Like Growth Factor I Sales (K Units) Comparison by Types (2012-2023)
1.2.2 Europe Insulin Like Growth Factor I Sales (K Units) Market Share by Types in 2017
1.2.3 CIGB-845
1.2.4 Dusigitumab
1.2.5 GM-6
1.2.6 M-610.27
1.2.7 M-630
1.2.8 Others
1.3 Europe Insulin Like Growth Factor I Market by Application/End Users
1.3.1 Europe Insulin Like Growth Factor I (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Alzheimer's Disease
1.3.3 Breast Cancer
1.3.4 Huntington Disease
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Europe Insulin Like Growth Factor I Market by Region
1.4.1 Europe Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 Germany Status and Prospect (2012-2023)
1.4.3 UK Status and Prospect (2012-2023)
1.4.4 France Status and Prospect (2012-2023)
1.4.5 Russia Status and Prospect (2012-2023)
1.4.6 Benelux Status and Prospect (2012-2023)
1.4.7 Italy Status and Prospect (2012-2023)
1.4.8 Spain Status and Prospect (2012-2023)
1.5 Europe Sales and Revenue ofSales and Revenue of Insulin Like Growth Factor I (2012-2023)
1.5.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2023)
1.5.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
2 Industrial Chain Analysis
2.1 Industry Chain Structure of Insulin Like Growth Factor I
2.2 Raw Material Analysis of Insulin Like Growth Factor I
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Insulin Like Growth Factor I
2.4 Other Costs Analysis of Insulin Like Growth Factor I
2.5 Manufacturing Cost Structure Analysis of Insulin Like Growth Factor I
2.6 Manufacturing Process Analysis of Insulin Like Growth Factor I
2.7 Raw Materials Sources of Insulin Like Growth Factor I Major Manufacturers in 2018
2.8 Downstream Buyers
3 Europe Insulin Like Growth Factor I Players/Suppliers Profiles and Sales Data
3.1 Boehringer Ingelheim GmbH
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Insulin Like Growth Factor I Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 Boehringer Ingelheim GmbH Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Different Applications and Its Application Share
3.2 Genervon Biopharmaceuticals LLC
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Insulin Like Growth Factor I Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Genervon Biopharmaceuticals LLC Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Different Applications and Its Application Share
3.3 MedImmune LLC
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Insulin Like Growth Factor I Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 MedImmune LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 MedImmune LLC Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 MedImmune LLC Insulin Like Growth Factor I Volume in Different Applications and Its Application Share
3.4 Regulaxis SAS
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Insulin Like Growth Factor I Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Regulaxis SAS Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 Regulaxis SAS Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 Regulaxis SAS Insulin Like Growth Factor I Volume in Different Applications and Its Application Share
3.5 ...
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Insulin Like Growth Factor I Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 ... Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 ... Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 ... Insulin Like Growth Factor I Volume in Different Applications and Its Application Share
4 Europe Insulin Like Growth Factor I Competition by Players/Manufacturers, Region, Type and Application
4.1 Europe Insulin Like Growth Factor I Market Competition by Players/Manufacturers
4.1.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 Europe Insulin Like Growth Factor I Sales and Revenue by Type
4.2.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Europe Insulin Like Growth Factor I Sales and Revenue by Application
4.3.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 Europe Insulin Like Growth Factor I Sales (K Units) by Application
5 Germany Insulin Like Growth Factor I (Sales, Revenue and Price)
5.1 Germany Insulin Like Growth Factor I Sales and Value (2012-2017)
5.1.1 Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
5.1.2 Germany Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
5.1.3 Germany Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
5.2 Germany Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
5.3 Germany Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
6 UK Insulin Like Growth Factor I (Sales, Revenue and Price)
6.1 UK Insulin Like Growth Factor I Sales and Value (2012-2017)
6.1.1 UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
6.1.2 UK Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
6.1.3 UK Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
6.2 UK Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
6.3 UK Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
7 France Insulin Like Growth Factor I (Sales, Revenue and Price)
7.1 France Insulin Like Growth Factor I Sales and Value (2012-2017)
7.1.1 France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
7.1.2 France Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
7.1.3 France Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
7.2 France Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
7.3 France Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
8 Russia Insulin Like Growth Factor I (Sales, Revenue and Price)
8.1 Russia Insulin Like Growth Factor I Sales and Value (2012-2017)
8.1.1 Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
8.1.2 Russia Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
8.1.3 Russia Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
8.2 Russia Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
8.3 Russia Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
9 Benelux Insulin Like Growth Factor I (Sales, Revenue and Price)
9.1 Benelux Insulin Like Growth Factor I Sales and Value (2012-2017)
9.1.1 Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
9.1.2 Benelux Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
9.1.3 Benelux Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
9.2 Benelux Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
9.3 Benelux Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
10 Italy Insulin Like Growth Factor I (Sales, Revenue and Price)
10.1 Italy Insulin Like Growth Factor I Sales and Value (2012-2017)
10.1.1 Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
10.1.2 Italy Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
10.1.3 Italy Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
10.2 Italy Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
10.3 Italy Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
11 Spain Insulin Like Growth Factor I (Sales, Revenue and Price)
11.1 Spain Insulin Like Growth Factor I Sales and Value (2012-2017)
11.1.1 Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
11.1.2 Spain Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017)
11.1.3 Spain Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
11.2 Spain Insulin Like Growth Factor I Sales (K Units) and Market Share by Type
11.3 Spain Insulin Like Growth Factor I Sales (K Units) and Market Share by Application
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Direct Marketing
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Europe Insulin Like Growth Factor I Market Forecast (2018-2023)
13.1 Europe Insulin Like Growth Factor I Sales (K Units), Revenue and Price Forecast (2018-2023)
13.1.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast (2018-2023)
13.1.2 Europe Insulin Like Growth Factor I Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Europe Insulin Like Growth Factor I Price and Trend Forecast (2018-2023)
13.2 Europe Insulin Like Growth Factor I Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
13.2.2 Europe Insulin Like Growth Factor I Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.3 Germany Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 UK Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 France Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Russia Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 France Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Italy Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.9 Spain Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023)
13.3 Europe Insulin Like Growth Factor I Sales, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Europe Insulin Like Growth Factor I Sales Forecast by Type (2018-2023)
13.3.2 Europe Insulin Like Growth Factor I Revenue Forecast by Type (2018-2023)
13.3.3 Europe Insulin Like Growth Factor I Price Forecast by Type (2018-2023)
13.4 Europe Insulin Like Growth Factor I Sales Forecast by Application (2018-2023)
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer
List of Figures, Tables and Charts Available in Europe Insulin Like Growth Factor I Market Report 2018
List of Tables and FiguresFigure Europe Market Size (Million USD) Comparison 2012-2023
Table Europe Market Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions 2012-2023
Table Europe Insulin Like Growth Factor I Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Europe Insulin Like Growth Factor I Sales (K Units) by Application (2016-2023)
Figure Product Picture of Insulin Like Growth Factor I
Table Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share by Types in 2017
Figure CIGB-845 Picture
Figure Dusigitumab Picture
Figure GM-6 Picture
Table Europe Insulin Like Growth Factor I Sales (K Units) Comparison by Applications (2012-2023)
Figure Europe Sales Market Share of Insulin Like Growth Factor I by Applications in 2017
Figure Alzheimer's Disease Picture
Figure Breast Cancer Picture
Figure Huntington Disease Picture
Table Europe Market Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions 2012-2023
Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2023)
Figure Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023)
Figure New Project SWOT Analysis of Insulin Like Growth Factor I
Table Industry News List of Insulin Like Growth Factor I
Figure Industry Chain Structure of Insulin Like Growth Factor I
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Insulin Like Growth Factor I in 2017
Figure Manufacturing Process Analysis of Insulin Like Growth Factor I
Table Raw Materials Sources of Insulin Like Growth Factor I Major Manufacturers Europe
Table Major Buyers of Insulin Like Growth Factor I
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Genervon Biopharmaceuticals LLC Basic Information List
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table MedImmune LLC Basic Information List
Table MedImmune LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure MedImmune LLC Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure MedImmune LLC Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure MedImmune LLC Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table MedImmune LLC Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table MedImmune LLC Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table MedImmune LLC Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Regulaxis SAS Basic Information List
Table Regulaxis SAS Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Regulaxis SAS Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Regulaxis SAS Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Regulaxis SAS Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Regulaxis SAS Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Regulaxis SAS Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Regulaxis SAS Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table ... Basic Information List
Table ... Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure ... Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure ... Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure ... Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table ... Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table ... Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table ... Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Basic Information List
Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Basic Information List
Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Basic Information List
Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Basic Information List
Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Company Basic Information List
Table Company Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Company Insulin Like Growth Factor I Sales Growth Rate (2012-2017)
Figure Company Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017)
Figure Company Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017)
Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Company Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share
Table Company Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share
Table Company Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share
Table Europe Insulin Like Growth Factor I Sales (K Units) by Players/Manufacturers (2012-2017)
Table Europe Insulin Like Growth Factor I Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Europe Insulin Like Growth Factor I Sales Market Share (%) by Players/Manufacturers
Figure 2017 Europe Insulin Like Growth Factor I Sales Share by Players/Manufacturers
Table Europe Insulin Like Growth Factor I Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Europe Insulin Like Growth Factor I Revenue Market Share (%) Players/Manufacturers (2012-2017)
Figure 2016 Europe Insulin Like Growth Factor I Revenue Market Share (%) Players
Figure 2017 Europe Insulin Like Growth Factor I Revenue Market Share (%) Players
Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share (%) by Type (2012-2017)
Table Europe Insulin Like Growth Factor I Sales Share by Type (2012-2017)
Figure Sales Market Share of Insulin Like Growth Factor I by Type (2012-2017)
Figure Europe Insulin Like Growth Factor I Sales Growth Rate (%) by Type (2012-2017)
Table Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share (%) Type (2012-2017)
Table Europe Insulin Like Growth Factor I Revenue Market Share (%) Type (2012-2017)
Figure Revenue Market Share of Insulin Like Growth Factor I by Type (2012-2017)
Figure Europe Insulin Like Growth Factor I Revenue Growth Rate by Type (2012-2017)
Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Regions (2012-2017)
Table Europe Insulin Like Growth Factor I Sales Share by Regions (2012-2017)
Figure Sales Market Share of Insulin Like Growth Factor I by Regions (2012-2017)
Figure Europe Insulin Like Growth Factor I Sales Market Share by Regions in 2017
Table Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Europe Insulin Like Growth Factor I Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share of Insulin Like Growth Factor I by Regions (2012-2017)
Figure Europe Insulin Like Growth Factor I Revenue Market Share by Regions in 2017
Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Application (2012-2017)
Table Europe Insulin Like Growth Factor I Sales Share (%) by Application (2012-2017)
Figure Europe Insulin Like Growth Factor I Sales Market Share by Application (2012-2017)
Figure Europe Insulin Like Growth Factor I Sales Market Share by Application (2012-2017)
Figure Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) (2012-2017)
Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Germany Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table Germany Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table Germany Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure UK Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table UK Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table UK Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure UK Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table UK Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table UK Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure UK Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure France Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table France Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table France Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure France Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table France Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table France Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure France Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Russia Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table Russia Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table Russia Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Italy Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table Italy Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table Italy Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Benelux Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table Benelux Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table Benelux Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Figure Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017)
Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Spain Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017)
Table Spain Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017)
Table Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017)
Figure Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017
Table Spain Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017)
Table Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017)
Figure Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017
Table Distributors/Traders List
Figure Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast (2018-2023)
Figure Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Europe Insulin Like Growth Factor I Price and Trend Forecast (2018-2023)
Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Regions (2018-2023)
Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share Forecast by Regions (2018-2023)
Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share Forecast by Regions in 2023
Table Europe Insulin Like Growth Factor I Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Regions (2018-2023)
Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Regions in 2023
Figure Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Type (2018-2023)
Figure Europe Insulin Like Growth Factor I Sales Market Share Forecast by Type (2018-2023)
Table Europe Insulin Like Growth Factor I Revenue (Million USD) Forecast by Type (2018-2023)
Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Type (2018-2023)
Table Europe Insulin Like Growth Factor I Price (USD/Unit) Forecast by Type (2018-2023)
Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Application (2018-2023)
Figure Europe Insulin Like Growth Factor I Sales Market Share Forecast by Application (2018-2023)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Europe Insulin Like Growth Factor I Market Report 2018
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Regulaxis SAS
...
...
